Home Cart Sign in  
Chemical Structure| 77284-32-3 Chemical Structure| 77284-32-3
Chemical Structure| 77284-32-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fmoc-Nle-OH is an amino acid derivative commonly used in organic synthesis.

Synonyms: Fmoc-L-Norleucine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fmoc-Nle-OH

CAS No. :77284-32-3
Formula : C21H23NO4
M.W : 353.41
SMILES Code : CCCC[C@@H](C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C13)=O
Synonyms :
Fmoc-L-Norleucine
MDL No. :MFCD00037537
InChI Key :VCFCFPNRQDANPN-IBGZPJMESA-N
Pubchem ID :7009636

Safety of Fmoc-Nle-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Fmoc-Nle-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 77284-32-3 ]

[ 77284-32-3 ] Synthesis Path-Downstream   1~26

  • 1
  • [ 29022-11-5 ]
  • [ 35737-15-6 ]
  • [ 77128-73-5 ]
  • [ 77284-32-3 ]
  • Fmoc-D-Asp(t-Bu)-OH, Hpa-OSu [ No CAS ]
  • (R)-N-((S)-1-Carbamoyl-2-phenyl-ethyl)-3-{(S)-2-[(S)-2-(2-{(S)-2-[2-(4-hydroxy-phenyl)-acetylamino]-hexanoylamino}-acetylamino)-3-(1H-indol-3-yl)-propionylamino]-hexanoylamino}-N-methyl-succinamic acid [ No CAS ]
  • 2
  • [ 67-56-1 ]
  • [ 122889-11-6 ]
  • [ 77284-32-3 ]
  • [ 708-06-5 ]
  • Gly-Wang resin [ No CAS ]
  • [(S)-2-((S)-3-Benzyloxy-2-[1-(2-hydroxy-naphthalen-1-yl)-meth-(E)-ylidene]-amino}-propionylamino)-hexanoylamino]-acetic acid methyl ester [ No CAS ]
  • 3
  • [ 67-56-1 ]
  • [ 96402-49-2 ]
  • [ 77284-32-3 ]
  • [ 708-06-5 ]
  • Gly-Wang resin [ No CAS ]
  • [(S)-2-((S)-2-[1-(2-Hydroxy-naphthalen-1-yl)-meth-(E)-ylidene]-amino}-3-naphthalen-1-yl-propionylamino)-hexanoylamino]-acetic acid methyl ester [ No CAS ]
  • 4
  • [ 67-56-1 ]
  • [ 139090-50-9 ]
  • [ 77284-32-3 ]
  • [ 708-06-5 ]
  • Gly-Wang resin [ No CAS ]
  • C33H42N6O7S [ No CAS ]
  • 5
  • [ 71989-18-9 ]
  • [ 132684-59-4 ]
  • [ 77284-32-3 ]
  • [ 135112-28-6 ]
  • [ 125238-99-5 ]
  • N-(9-fluorenylmethoxycarbonyl)-3-(β-naphthyl)-L-alanine [ No CAS ]
  • [ 1349220-85-4 ]
  • 6
  • [ 159610-89-6 ]
  • [ 68858-20-8 ]
  • [ 71989-38-3 ]
  • [ 71989-26-9 ]
  • [ 77284-32-3 ]
  • [ 94744-50-0 ]
  • N,N'-bis(tert-butyloxycarbonyl)-L-lysine dicyclohexylamine salt [ No CAS ]
  • [ 198561-07-8 ]
  • [ 1443329-49-4 ]
  • 7
  • [ 159610-89-6 ]
  • [ 108-24-7 ]
  • [ 86123-10-6 ]
  • [ 109425-51-6 ]
  • [ 77284-32-3 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • [ 198561-07-8 ]
  • Ac-Nle-Pra-His-D-Phe-Arg-Trp-Nle(ε-N3)-NH2 [ No CAS ]
  • 8
  • [ 159610-89-6 ]
  • [ 108-24-7 ]
  • [ 86123-10-6 ]
  • [ 109425-51-6 ]
  • [ 77284-32-3 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • [ 198561-07-8 ]
  • Ac-Nle-Nle(N<SUB>3</SUB>)-His-D-Phe-Arg-Trp-Pra-NH<SUB>2</SUB> [ No CAS ]
  • 9
  • [ 56-45-1 ]
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • C22H26N2O3 [ No CAS ]
  • [ 71989-31-6 ]
  • [ 135944-05-7 ]
  • [ 91000-69-0 ]
  • [ 77284-32-3 ]
  • [ 109425-56-1 ]
  • [ 116611-64-4 ]
  • PyrRPRLSHKGPNleP(α-Me)Phe [ No CAS ]
  • 10
  • (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid [ No CAS ]
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 1311933-83-1 ]
  • [ 71989-31-6 ]
  • [ 71989-33-8 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 132327-80-1 ]
  • [ 77284-32-3 ]
  • C122H179N16O22Pol [ No CAS ]
  • 11
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • Boc-His(Trt)-Gly-Asp(tBu)-Gly-OH [ No CAS ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 77284-32-3 ]
  • [ 104091-08-9 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Fmoc-Thr(Pg)-OH [ No CAS ]
  • Fmoc-Ser(Pg)-OH [ No CAS ]
  • C151H232N42O48 [ No CAS ]
  • 12
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • Boc-His(Trt)-Gly-Asp(tBu)-Gly-OH [ No CAS ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 96402-49-2 ]
  • [ 77284-32-3 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Fmoc-Thr(Pg)-OH [ No CAS ]
  • Fmoc-Ser(Pg)-OH [ No CAS ]
  • C160H237N41O47 [ No CAS ]
  • 13
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • Boc-His(Trt)-Gly-Asp(tBu)-Gly-OH [ No CAS ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 77284-32-3 ]
  • [ 32926-43-5 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Fmoc-Thr(Pg)-OH [ No CAS ]
  • Fmoc-Ser(Pg)-OH [ No CAS ]
  • C153H233N43O47 [ No CAS ]
  • 14
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • Boc-His(Trt)-Gly-Asp(tBu)-Gly-OH [ No CAS ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 77284-32-3 ]
  • [ 32926-43-5 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Fmoc-Thr(Pg)-OH [ No CAS ]
  • Fmoc-Ser(Pg)-OH [ No CAS ]
  • C153H233N43O47 [ No CAS ]
  • 15
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 35661-38-2 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 77284-32-3 ]
  • [ 32926-43-5 ]
  • [ 143824-78-6 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Fmoc-Thr(Pg)-OH [ No CAS ]
  • Fmoc-Ser(Pg)-OH [ No CAS ]
  • C152H234N42O48 [ No CAS ]
  • 16
  • [ 29022-11-5 ]
  • [ 35661-39-3 ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-38-3 ]
  • [ 77284-32-3 ]
  • [ 104091-08-9 ]
  • [ 143824-78-6 ]
  • [ 137076-54-1 ]
  • DOTA-DGlu-Ala-Tyr-Gly-Trp-Nle-Asp-Phe-NH<SUB>2</SUB>, Nle=norleucine, DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [ No CAS ]
  • 17
  • [ 35661-39-3 ]
  • [ 35661-38-2 ]
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 135112-28-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • [ 112883-41-7 ]
  • C62H84N9O13Pol [ No CAS ]
  • 18
  • [ 35661-38-2 ]
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 135112-28-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • [ 112883-41-7 ]
  • C70H99N10O14Pol [ No CAS ]
  • 19
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 135112-28-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • [ 112883-41-7 ]
  • C71H102N9O13Pol [ No CAS ]
  • 20
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • [ 112883-41-7 ]
  • C66H93N8O12Pol [ No CAS ]
  • 21
  • [ 35661-38-2 ]
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • [ 144701-24-6 ]
  • C59H79N8O12Pol [ No CAS ]
  • 22
  • [ 35661-38-2 ]
  • [ 77284-32-3 ]
  • [ 71989-31-6 ]
  • [ 135112-28-6 ]
  • [ 143674-78-6 ]
  • [ 170642-27-0 ]
  • C66H91N10O14Pol [ No CAS ]
  • 23
  • N-alpha-Fmoc-N-beta-O-t-butyl-L-aspartyl-N-α-(2,4-dimethoxybenzyl)glycine [ No CAS ]
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 35661-60-0 ]
  • [ 13734-34-4 ]
  • [ 957780-56-2 ]
  • [ 35661-39-3 ]
  • [ 920519-33-1 ]
  • (2S)-N-((9H-fluoren-9-ylmethyloxy)carbonyl)aspartic acid-4-((3-ethyl)pent-3-yl) ester [ No CAS ]
  • Fmoc-Gly-Ser(ψMe,MePro)-OH [ No CAS ]
  • Fmoc-Gln(Trt)-Thr(ψMe,MePro)-OH [ No CAS ]
  • [ 71989-31-6 ]
  • [ 35661-40-6 ]
  • [ 71989-33-8 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-38-3 ]
  • [ 71989-26-9 ]
  • [ 103213-32-7 ]
  • [ 71989-35-0 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 86060-81-3 ]
  • [ 109425-51-6 ]
  • [ 77284-32-3 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • [Cys105,Nle125,170,Cys(Acm)165,182,189,Asn107,Asp109](105-191)hGH-NH2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
101.1 mg General procedure: The syntheses of the fragments were performed on an automatic peptide synthesizer under microwave conditions using an 8-fold excess of 0.5 M amino acids, 0.5 M HATU/NMP, 2 M DIEA /NMP or 1.0 M DIC/NMP and 0.5 M Oxyma /NMP. The final concentration of Fmoc-amino acids was 0.2 M. The coupling cycles were conducted according to Table 1. Fmoc deprotection was carried out using 35% piperidine/NMP containing 0.1 M HOBt at room temperature for 2 and 6 min, followed by 4 min at 48 C.
  • 24
  • [ 35661-39-3 ]
  • C32H34N2O8 [ No CAS ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 108-24-7 ]
  • [ 96402-49-2 ]
  • [ 77284-32-3 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • [ 268209-75-2 ]
  • C52H71N13O12 [ No CAS ]
  • 25
  • [ 3235-69-6 ]
  • [ 159610-93-2 ]
  • C26H19N2O5Pol [ No CAS ]
  • [ 132684-59-4 ]
  • [ 77284-32-3 ]
  • Mor-Hfe-Ser(Me)-Nle-ACC [ No CAS ]
  • 26
  • [ 3235-69-6 ]
  • [ 159610-93-2 ]
  • [ 35661-60-0 ]
  • C26H19N2O5Pol [ No CAS ]
  • [ 77284-32-3 ]
  • Mor-Nle-Ser(Me)-Leu-ACC [ No CAS ]
 

Historical Records

Technical Information

Categories